Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Profound Medical Q2 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $2.233M Beat $2.100M Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:38pm
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.30) by 6.67 percent. This is a 20 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $2.233 million which beat the analyst consensus estimate of $2.100 million by 6.33 percent. This is a 39.39 percent increase over sales of $1.602 million the same period last year.

Posted In: PROF


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist